Patent Assignment
Reel/Frame 022846/0320
Assignment of Assignor's Interest
Recorded: 2009-06-19
Pages: 40
Assignor
NITROMED, INC.
Executed: 2009-04-20
Assignee
NICOX S.A.
LES TAISSOUNIERES 1681 ROUTE DES DOLINES - BAT HB4, SOPHIA ANTIPOLIS, 06 906, FRANCE
Covered Properties
(172)
Substituted Aryl Compounds as Novel Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
PCT:
PCT/US2001/048823 ↗
Nitrosated and Nitrosylated Nebivolo and Its Metabolites, Compositions and Methods for Use
PCT:
PCT/US2002/013667 ↗
Nitric Oxide Donors, Compositions and Methods of Use
PCT:
PCT/US2003/010562 ↗
Nitrosated and/or Nitrosylated Cyclooygenase-2 Selective Inhibitors, Compositions and Methods of Use
PCT:
PCT/US2003/018052 ↗
Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
PCT:
PCT/US2003/019850 ↗
Oxime and/or Hydrazone Containing Nitrosated and/or Nitrosylated Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
PCT:
PCT/US2003/020421 ↗
Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use
PCT:
PCT/US2003/021026 ↗
Nitrosated Proton Pump Inhibitors, Compositions and Methods of Use
PCT:
PCT/US2003/023963 ↗
Inhibition of Cyclooxygenase-3 Mediated Diseases and Disorders
PCT:
PCT/US2003/028471 ↗
Nitrosated and Nitrosylated Rapamycin Compounds, Compositions and Methods of Use
PCT:
PCT/US2003/039562 ↗
Apparatus for Microfluidic Processing and Reading of Biochip Arrays
PCT:
PCT/US2004/002691 ↗
Nitrosated and Nitrosylated Compounds, Compositions and Methods of Use
PCT:
PCT/US2004/007943 ↗
Nitrosated and Nitrosylated Cardiovascular Compounds, Compositions and Methods of Use
PCT:
PCT/US2004/026910 ↗
Nitrosated Glutamic Acid Compounds, Compositions and Methods of Use
PCT:
PCT/US2004/031372 ↗
Nitric Oxide Releasing Pyruvate Compounds, Composition and Methods of Use
PCT:
PCT/US2004/041069 ↗
Nitrosated and/or Nitrosylated Compounds, Compositions and Methods of Use
PCT:
PCT/US2005/002257 ↗
Nitrosated and Nitrosylated Compounds, Compositions and Methods for the Treatment of Ophthalmic Disorders
PCT:
PCT/US2005/040314 ↗
Diuretic Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
PCT:
PCT/US2005/041321 ↗
Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Group Compositions and Methods of Use
PCT:
PCT/US2006/002199 ↗
Organic Nitric Oxide Donor Salts of Antimicrobial Compounds, Compositions and Methods of Use
PCT:
PCT/US2006/005416 ↗
Nitric Oxide Enhancing Diuretic Compounds, Compositions and Methods of Use
PCT:
PCT/US2006/006375 ↗
Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use
PCT:
PCT/US2006/006843 ↗
Organic Nitric Oxide Enhancing Salts of Angiotensin Ii Antagonists, Compositions and Methods of Use
PCT:
PCT/US2006/008441 ↗
2-Methyl Indole Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
PCT:
PCT/US2006/009127 ↗
Organic Nitric Oxide Enhancing Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
PCT:
PCT/US2006/009698 ↗
Organic Nitric Oxide Enhancing Salts of Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use
PCT:
PCT/US2006/019717 ↗
Cyclooxygenase-2 Selective Inhibitor Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use
PCT:
PCT/US2006/028856 ↗
Organic Nitric Oxide Enhancing Salts of Cyclooxygenase-2 Selective Inhibitors, Compositons and Methods of Use
PCT:
PCT/US2006/028952 ↗
Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use
PCT:
PCT/US2006/030287 ↗
Nitric Oxide Enhancing Angiotensin Ii Antagonist Compounds, Compositions and Methods of Use
PCT:
PCT/US2006/030733 ↗
Nitric Oxide Enhancing Glutamic Acid Compounds, Compositions and Methods of Use
PCT:
PCT/US2006/048193 ↗
Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use
PCT:
PCT/US2006/048194 ↗
Nitric Oxide Enhancing Prostaglandin Compounds, Compositions and Methods of Use
PCT:
PCT/US2007/006749 ↗
Organic Nitric Oxide Enhancing Salts of Prostaglandins, Compositions and Methods of Use
PCT:
PCT/US2007/008427 ↗
Nitroso Esters of Beta-Oxo-Amides and Aryl Propionic Acid Derivatives of Non-Steroidal Antiinflammatory Drugs
Patent:
6,051,588 →
Application:
08/425,090 →
Compositions and Methods to Prevent Toxicity Induced by Nonsteroidal Antiinflammatory Drugs
Patent:
5,703,073 →
Application:
08/543,208 →
Nitrosated and Nitrosylated Compounds and Compositions and Their Use for Treating Respiratory Disorders
Patent:
5,824,669 →
Application:
08/620,882 →
Condensate Colorimetric Nitrogen Oxide Analyzer
Patent:
6,033,368 →
Application:
08/623,643 →
Nitroso Esters of Beta-Oxo-Amides and Aryl Propionic Acid Derivatives of Non-Steroidal Antiinflammatory Drugs
Application:
08/899,238 →
Compositions and Methods to Prevent Toxicity Induced by Nonsteroidal Antiinflammatory Drugs
Patent:
6,057,347 →
Application:
08/931,564 →
Compositions and Methods to Prevent Toxicity Induced by Nonsteroidal Antiinflammatory Drugs
Application:
09/000,434 →
Nitrosated and Nitrosylated Steroids,Compositions,and Methods for Treating Respiratory Disorders
Patent:
6,197,762 →
Application:
09/157,242 →
Compounds, Compositions and Methods to Prevent Toxicity Induced by Nonsteroidal Antiinflammatory Drugs
Application:
09/182,433 →
Nitrosated and Nitrosylated Compounds, and Compositions and Their Use for Treating Respiratory Disorders
Patent:
37,116 →
Application:
09/219,476 →
Compositions and Methods to Prevent Toxicity Induced by Nonsteroidal Antiinflammatory Drugs
Patent:
6,083,515 →
Application:
09/235,801 →
Nitroso Esters of Beta-Oxo-Amides and Aryl Propionic Acid Derivatives of Non-Steroidal Antiinflammatory Drugs
Patent:
6,043,232 →
Application:
09/235,802 →
Compositions and Methods to Prevent Toxicity Induced by Nonsteroidal Antiflammatory Drugs
Patent:
6,048,858 →
Application:
09/235,803 →
Compositions and Methods to Prevent Toxicity Induced by Nonsteroidal Antiinflammatory Drugs
Patent:
6,043,233 →
Application:
09/235,804 →
Nitrosated and Nitrosylated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods Of
Patent:
6,297,260 →
Application:
09/429,019 →
H2 Receptor Antagonist Compounds in Combination with Nitric Oxide Donors, Compostions and Methods of Use
Condensate Colorimetric Nitrogen Oxide Analyzer
Patent:
6,419,634 →
Application:
09/494,536 →
Nitroso esters of bete-oxo-amides and aryl propionic acid derivatives of non-steroidal antininflammatory drugs
Patent:
6,143,734 →
Application:
09/495,251 →
Nitrosated and Nitrosylated Proton Pump Inhibitors Compositions and Methods of Use
Patent:
6,852,739 →
Application:
09/512,829 →
Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity
Patent:
6,323,234 →
Application:
09/518,541 →
Nitrosated and Nitrosylated Cyclooxygenase-2 Inhibitors, Compositions and Methods of Use
Infrared Thermograpy and Methods of Use
Nitrosated and Nitrosylated Nonsteroidal Antiinflammatory Compounds, Compositons and Methods of Use
Compositions and Methods to Prevent Toxicity Induced by Nonsteroidal Antiinflammatory Drugs
Patent:
6,482,846 →
Application:
09/941,690 →
Substituted Aryl Compounds as Novel Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
Cyclooxygenase-2 inhibitors, compositions and methods of use
Application:
10/102,865 →
Publication:
US 2002/0183366
Compositions and Methods to Prevent Toxicity Induced by Nonsteroidal Antiinflammatory Drugs
Nitrosated and Nitrosylated H2 Receptor Antagonist Compounds, Compositions and Methods of Use
Nitric oxide donors, compositions and methods of use related applications
Application:
10/407,420 →
Publication:
US 2003/0203915
Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
Application:
10/431,457 →
Publication:
US 2003/0207919
Nitrosated and Nitrosylated Cyclooxygenase-2 Inhibitors, Compositions and Methods of Use
Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
Application:
10/568,819 →
Publication:
US 2007/0238740
Nitrosated Glutamic Acid Compounds, Compositions and Methods of Use
Application:
10/573,030 →
Publication:
US 2007/0037821
Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
Application:
10/581,340 →
Publication:
US 2008/0287407
Nitrosated and/or nitrosylated compounds, compositions and methods of use
Application:
10/586,161 →
Publication:
US 2009/0131342
Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
Oxime and/or Hydrozone Containing Nitrosated and/or Nitrosylated Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use
Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
Nitrosated Proton Pump Inhibitors, Compositions and Methods of Use
Nitrosated and Nitrosylated Nebivolol and Its Metabolites, Compositions and Methods of Use
Nitrosated and/or Nitrosylated Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
Substituted Aryl Compounds as Novel Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
Compositions of S-Nitrosothiols and Methods of Use
Nitrosated and Nitrosylated Proton Pump Inhibitors, Compositions and Methods of Use
Nitrosated and Nitrosylated Diuretic Compounds, Compositions and Methods of Use
Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
Application:
10/930,901 →
Publication:
US 2005/0038029
Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
Application:
10/969,079 →
Publication:
US 2005/0059665
Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use
Nitrosated and Nitrosylated Rapamycin Compounds, Compositions and Methods of Use
Nebivolol and Its Metabolites in Combination with Nitric Oxide Donors, Compositions and Methods of Use
Nitrosated and Nitrosylated H2 Receptor Antagonist Compounds, Compositions and Methods of Use
Nitrosated and nitrosylated compounds, compositions and methods use
Application:
11/221,901 →
Publication:
US 2006/0009431
Nitric Oxide Enhancing Diuretic Compounds, Compositions and Methods of Use
Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
Nitric Oxide Enhancing Angiotensin Ii Antagonist Compounds, Compositions and Methods of Use
Application:
11/499,770 →
Publication:
US 2007/0032533
Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
Application:
11/505,905 →
Publication:
US 2006/0276439
Nitrosated and Nitrosylated H2 Receptor Antagonist Compounds, Compositions and Methods of Use
Nitrosated and Nitrosylated Cyclooxygenase-2 Inhibitors, Compositions and Methods of Use
Nitrosated and Nitrosylated Compounds, Compositions and Methods for the Treatment of Ophthalmic Disorders
Application:
11/667,272 →
Publication:
US 2008/0300292
Nitrosated Proton Pump Inhibitors, Compositions and Methods of Use
Application:
11/689,568 →
Publication:
US 2007/0179150
Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
Application:
11/705,773 →
Publication:
US 2007/0155734
Nitrosated and/or Nitrosylated Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
Diuretic Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
Application:
11/793,724 →
Publication:
US 2008/0275093
Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
Application:
11/795,769 →
Publication:
US 2008/0306041
Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
Application:
11/802,161 →
Publication:
US 2007/0238735
Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use
Application:
11/815,270 →
Publication:
US 2009/0012057
Organic Nitric Oxide Enhancing Salts of Angiotensin Ii Antagonists, Compositions and Methods of Use
Application:
11/815,518 →
Publication:
US 2009/0215838
Organic Nitric Oxide Donor Salts of Antimicrobial Compounds, Compositions and Methods of Use
Application:
11/883,445 →
Publication:
US 2009/0042819
Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
Application:
11/886,461 →
Publication:
US 2008/0293678
Organic Nitric Oxide Donor Salts of Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use
Application:
11/914,204 →
Publication:
US 2009/0048219
Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use
Application:
11/997,536 →
Publication:
US 2009/0018091
Nitric Oxide Enhancing Glutamic Acid Compounds, Compositions and Methods of Use
Application:
12/096,328 →
Publication:
US 2009/0053328
Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use
Application:
12/096,867 →
Publication:
US 2008/0293702
Nitric Oxide Donating Diuretic Compounds, Compositions and Methods of Use
Compositions and Methods to Prevent Toxicity Induced by Nonsteroidal Antiinflammatory Drugs
Application:
12/174,510 →
Publication:
US 2008/0275010
Nitrosated and Nitrosylated Cyclooxygenase-2 Inhibitors, Compositions and Methods of Use
Application:
12/196,184 →
Publication:
US 2009/0099139
Cyclooxygenase-2 Selective Inhibitors, Compositions and Methods of Use
Application:
12/210,776 →
Publication:
US 2009/0005350
Nitric Oxide Enhancing Prostaglandin Compounds, Compositions and Methods of Use
Nitrosated and Nitrosylated Proton Pump Inhibitors, Compositions and Methods for the Treatment and Prevention of Gastrointestinal Disorders
Application:
60/122,111 →
Nitrosated and Nitrosylated H2 Receptor Antagonist Compounds, Compositions and Methods of Use
Application:
60/140,839 →
Nitrosated and Nitrosylated Cyclooxygenase-2 Inhibitors, Compositions and Methods of Use
Application:
60/171,623 →
Infrared thermography and methods of use
Application:
60/202,935 →
Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
Application:
60/226,085 →
Substituted aryl compounds as novel cyclooxygenase 2 selective inhibitors compositions and methods of use
Application:
60/256,932 →
Cyclooxygenase inhibitors, compositions and methods of use
Application:
60/277,950 →
Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
Application:
60/287,725 →
Nitric oxide donors, compositions and methods of use
Application:
60/369,873 →
Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
Application:
60/387,433 →
Cyclooxygenase-2 selective inhibitors, compositions and methods of use
Application:
60/391,769 →
Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
Application:
60/392,044 →
Nitrosated non-steroidal antiinflammatory compounds, compositions and methods of use
Application:
60/393,111 →
Nitrosated non-steroidal antiinflammatory compounds, compositions and methods of use
Application:
60/397,979 →
Cyclooxygenase-2 selective inhibitors, compositions and methods of use
Application:
60/398,829 →
Nitrosated proton pump inhibitors, compositions and methods of use
Application:
60/399,715 →
Inhibition of cyclooxygenase-3 mediated diseases and disorders
Application:
60/409,913 →
Nitrosated and nitrosylated antiinflammatory compounds, compositions and methods of use
Application:
60/418,353 →
Nitrosated and nitrosylated rapamycin, compositions and methods of use
Application:
60/433,595 →
Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
Application:
60/449,798 →
Nitrosated and nitrosylated compounds, compositions and methods of use
Application:
60/453,963 →
Cyclooxygenase-2 selective inhibitors, compositions and methods of use
Application:
60/454,307 →
Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
Application:
60/456,182 →
Nitrosated and nitrosylated compounds, compositions and methods of use
Application:
60/482,134 →
Nitrosated and/or nitrosylated cardiovascular compounds, compositions and methods of use
Application:
60/498,309 →
Nitrosated glutamic acid compounds, compositions and methods of use
Application:
60/505,921 →
Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
Application:
60/513,215 →
Nitrosated and/or nitrosylated pyruvate compounds, compositions and methods of use
Application:
60/528,184 →
Nitrosated and/or nitrosylated cardiovascular compounds, compositions and methods of use
Application:
60/535,542 →
Nitrosated and/or nitrosylated compounds, compositions and methods of use
Application:
60/537,918 →
Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders
Application:
60/625,578 →
Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
Application:
60/627,177 →
Cardiovascular compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
Application:
60/645,140 →
Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use
Application:
60/653,120 →
Nitric oxide donating diuretic compounds, compositions and methods of use
Application:
60/655,414 →
Cardiovascular compound comprising heterocyclic nitric oxide donor groups, compositions and methods of use
Application:
60/656,544 →
Nitric oxide donating diuretic compounds, compositions and methods of use
Application:
60/656,545 →
Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
Application:
60/656,546 →
Organic nitric oxide donor salts of angiotensin II antagonists, compositions and methods of use
Application:
60/659,401 →
2-Methyl indole cyclooxygenase-2 selective inhibitors, compositions and methods of use
Application:
60/660,436 →
Organic nitric oxide donor salts of angiotensin converting enzyme inhibitors, compositions and methods of use
Application:
60/662,931 →
Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use
Application:
60/683,349 →
Nitric oxide donating diuretic compounds, compositions and methods of use
Application:
60/685,027 →
Nitric oxide donating diuretic compounds, compositions and methods of use
Application:
60/692,228 →
Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
Application:
60/692,231 →
Cyclooxygenase-2 selective inhibitors comprising heterocyclic nitric oxide donor groups, compositions and methods of use
Application:
60/702,639 →
Organic nitric oxide donor salts of cyclooxygenase-2 selective inhibitors, compositions and methods of use
Application:
60/702,984 →
Antimicrobial compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
Application:
60/704,426 →
Nitric oxide enhancing angiotensin II antagonist compounds, compositions and methods of use
Application:
60/706,005 →
Nitric oxide enhancing angiotensin II antagonist compounds, compositions and methods of use
Application:
60/706,419 →
Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use
Application:
60/741,454 →
Nitric oxide enhancing antimicrobial compounds, compositions and methods of use
Application:
60/741,455 →
Nitric oxide enhancing angiotensin II antagonist compounds, compositions and methods of use
Application:
60/748,579 →
Nitric oxide enhancing diuretic compounds, compositions and methods of use
Application:
60/749,853 →
Organic nitric oxide donor salts of angiotensin II antagonists, compositions and methods of use
Application:
60/750,773 →
Nitric oxide enhancing glutamic acid compounds, compositions and methods of use
Application:
60/751,637 →
Nitric oxide releasing pyruvate compounds, compositions and methods of use
Application:
60/753,971 →
Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
Application:
60/786,689 →
Organic nitric oxide enhancing salts or prostaglandins, compositions and methods of use
Application:
60/792,644 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 19, 1995
From: GARVEY, DAVID S.; LETTS, L. GORDON; RENFROE, H. BURT; TAM, SANG WILLIAM
To: NITROMED, INC.
Reel/Frame 007485/0695 →
Assignment of Assignor's Interest
Oct 13, 1995
From: GARVEY, DAVID S.; LETTS, L. GORDON; RENFROE, H. BURT; TAM, SANG WILLIAM
To: NITROMED, INC.
Reel/Frame 007714/0994 →
Assignment of Assignor's Interest
Jun 12, 1996
From: GARVEY, DAVID S.; LETTS, L. GORDON; RENFROE, H. BURT; RICHARDSON, STEWART K.
To: NITROMED, INC.
Reel/Frame 008090/0389 →
Assignment of Assignor's Interest
Nov 4, 1996
From: NITROMED, INC.
To: HEALTHCARE VENTURES III L.P. AND HEALTHCARE VENTURES IV L.P.
Reel/Frame 008206/0509 →
Assignment of Assignor's Interest
Nov 4, 1996
From: NITROMED, INC.
To: HEALTHCARE VENTURES III L.P.; HEALTHCARE VENTURES IV L.P.
Reel/Frame 008204/0307 →
Re-Record to Correct the Address of the Receiving Party on a Document Previously Recorded at Reel 8206/Frame 0509.
Feb 5, 1997
From: NITROMED, INC.
To: HEALTHCARE VENTURES III, L.P.; HEALTHCARE VENTURES IV, L.P.
Reel/Frame 008333/0289 →
Correction of Assignment to Correct the Assignee's Address, Previously Recorded 8204, Frame 0307.
Feb 5, 1997
From: NITROMED, INC.
To: HEALTHCARE VENTURES III L.P.; HEALTHCARE VENTURES IV L.P.
Reel/Frame 008341/0580 →
Assignment of Assignor's Interest
Jan 30, 1998
From: GARVEY, DAVID S.; LETTS, L. GORDON; RENFROE, H. BURT; TANG, SANG W.
To: NITROMED, INC.
Reel/Frame 009029/0463 →
Assignment of Assignor's Interest
Jan 13, 1999
From: BANDARAGE, UPUL K.; DONG, QING; FANG, XINQIN; GARVEY, DAVID S.
To: NITROMED, INC.
Reel/Frame 009727/0911 →
Assignment of Assignor's Interest
Dec 3, 1999
From: GASTON, BENJAMIN M.; HUNT, JOHN F.
To: NITROMED, INC.
Reel/Frame 010409/0848 →
Assignment of Assignor's Interest
May 1, 2002
From: GARVEY, DAVID S.
To: NITROMED, INC.
Reel/Frame 012872/0602 →
Assignment of Assignor's Interest
Mar 15, 2004
From: EARL, RICHARD A.; GARVEY, DAVID S.; GASTON, RICKY D.; LIN, CHIA-EN
To: NITROMED, INC.
Reel/Frame 015123/0946 →
Assignment of Assignor's Interest
Sep 27, 2004
From: GARVEY, DAVID S.; EARL, RICHARD A.; EZAWA, MAIKO; FANG, XINQIN
To: NITROMED, INC.
Reel/Frame 015842/0699 →
Assignment of Assignor's Interest
Dec 10, 2004
From: GARVEY, DAVID S.; FANG, XINQIN; KHANAPURE, SUBHASH P.; RANATUNGE, RAMANI R.
To: NITROMED, INC.
Reel/Frame 016070/0203 →
Assignment of Assignor's Interest
Nov 8, 2005
From: GARVEY, DAVID S.; LETTS, L. GORDON
To: NITROMED, INC.
Reel/Frame 017244/0545 →
Assignment of Assignor's Interest
Nov 15, 2005
From: GARVEY, DAVID S.; RANATUNGE, RAMANI R.
To: NITROMED, INC.
Reel/Frame 017260/0855 →
Assignment of Assignor's Interest
Jan 23, 2006
From: GARVEY, DAVID S.
To: NITROMED, INC.
Reel/Frame 017489/0825 →
Assignment of Assignor's Interest
Feb 16, 2006
From: ELLIS, JAMES L.; GARVEY, DAVID S.; LIN, CHIA-EN
To: NITROMED, INC.
Reel/Frame 017608/0498 →
Assignment of Assignor's Interest
Feb 28, 2006
From: GARVEY, DAVID S.
To: NITROMED, INC.
Reel/Frame 017666/0286 →
Assignment of Assignor's Interest
Mar 9, 2006
From: GARVEY, DAVID S.; CAI, XIONG; LIN, CHIA-EN; RANATUNGE, RAMANI R.
To: NITROMED, INC.
Reel/Frame 017711/0331 →
Assignment of Assignor's Interest
Mar 13, 2006
From: WEY, SHIOW-JYI; GARVEY, DAVID S.; FANG, XINQIN; RICHARDSON, STEWART K.
To: NITROMED, INC.
Reel/Frame 017652/0535 →
Assignment of Assignor's Interest
Mar 17, 2006
From: GARVEY, DAVID S.
To: NITROMED, INC.
Reel/Frame 017768/0818 →
Assignment of Assignor's Interest
May 23, 2006
From: GARVEY, DAVID S.
To: NITROMED, INC.
Reel/Frame 017984/0313 →
Assignment of Assignor's Interest
Jul 26, 2006
From: GARVEY, DAVID S.
To: NITROMED, INC.
Reel/Frame 018145/0228 →
Assignment of Assignor's Interest
Jul 27, 2006
From: GARVEY, DAVID S.
To: NITROMED, INC.
Reel/Frame 018145/0225 →